You are currently browsing the archives for 6 January 2017.
Displaying 1 - 2 of 2 entries.

In recent years.

The use of melatonin to regulate sleep is not the only working at the Institute of Biotechnology of the UGR conducted. In recent years, professors Acu? A Escames and have demonstrated that this substance is also useful to slow down the aging of cells to treat diseases such as Parkinson’s disease and to slow cell death by severe infectious processes that affect the entire organism technically known to causes sepsis. She is currently working on a clinical trial of Phase II, the therapeutic of melatonin in septic shock patients, finances finances of the Health Institute Carlos III.

Ability Medicines Agency in 2007 authorized the use of melatonin for this type of. , after years of debate about the convenience of this measure Where there at the appointed hour.

On 9 March 2009 http://nolvadex.eu/effets-secondaires-de-tamoxifene.html.

On 9 March 2009, President Obama lifted the ban, which use of federal funds use of federal funds for embryonic stem cell research to cell lines that after 9 August had been created in 2001 restricted http://nolvadex.eu/effets-secondaires-de-tamoxifene.html . ‘More than a thousand lines have been derived since August 9, 2001, many with attributes benefit of medical research,’said Daley, whose own lab has derived 18 new stem cell lines. Until the change in policy, these lines are examined only by private means. Obama called for the National Institutes of Health set up strict guidelines to ensure that new stem cell lines ethical practices ethical practices.

Source: NovartisNovartis exclusive rights to develop and commercialize Debio 025 , a potential first-in – class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Agreement, Novartis won, the first in a new class of drugs called cyclophilin inhibitors which could be part of the the future standard of treatment for the disease.